EQT targets surgical technology with Corza Biosurgery deal
Global investment firm EQT is to acquire the biosurgery business unit from Chicago-based private equity firm GTCR’s portfolio company, Corza Medical. Financial details of the transaction remain undisclosed. The deal, through the EQT X fund, is expected to close in Q4 2026, subject to regulatory clearances and customary closing conditions. The divestiture represents a significant corporate carve-out for Corza Medical. Under…